Cercetătorii fac progrese în tratarea uneia dintre cele mai grave complicații ale cancerului

Recent research indicates that cachexia, a severe complication of cancer, may become treatable. Scientists have made significant strides in understanding the mechanisms behind this condition, which affects 50-80% of cancer patients. New findings reveal that cachexia is driven by complex inflammatory and metabolic processes initiated by tumors. A promising treatment involves an antibody that blocks the GDF15 protein, which suppresses appetite. Clinical trials show that patients receiving this treatment gained weight and reported increased appetite. Researchers are also working to identify biomarkers for early detection and tailored therapies, raising hopes for effective management of cachexia in the future.